Stampa…

Hai cercato: 3-Amino-2-bromophenol


51 021  risultati sono stati trovati

Sort Results

Visualizzazione a lista Nuova Visualizzazione
SearchResultCount:"51021"
Descrizione: Soluble in DMSO and 1N NaOH (2,0 mg/ ml).
Codice catalogo: ICNA0215474001
UOM: 1 * 1 g
Codice articolo fornitore: 0215474001
Codice articolo locale: ICNA0215474001
Fornitore: MP Biomedicals


Descrizione: Glicina, Millipore®
Codice catalogo: 357002-1
UOM: 1 * 1 kg
Codice articolo fornitore: 357002-1
Codice articolo locale: CALB357002-1
Fornitore: Merck Millipore (Calbiochem‎)


Descrizione: Melamine statement (available upon request) BSE/TSE statement (available upon request)
Codice catalogo: SPCMAM151-25KGBL
UOM: 1 * 25 kg
Codice articolo fornitore: AM151-25KGBL
Codice articolo locale: SPCMAM151-25KGBL
Fornitore: Spectrum Chemical


Descrizione: Tobramycin
Codice catalogo: EHERCA17588000
UOM: 1 * 0,1 g
Codice articolo fornitore: CA17588000
Codice articolo locale: EHERCA17588000
Fornitore: EHRENSTORFER


Descrizione: Glycine is frequently used as a component of electrophoresis buffers, especially in the Laemmli discontinuous buffer system for SDS-PAGE.
Codice catalogo: 17-1323-01
UOM: 1 * 500 g
Codice articolo fornitore: 17-1323-01
Codice articolo locale: GEHE17-1323-01
Fornitore: Cytiva

MSDS


Descrizione: L(+)-Glutammina reagente per coltura cellulare
Codice catalogo: J60573.14
UOM: 1 * 25 g
Codice articolo fornitore: J60573.14
Codice articolo locale: ALFAJ60573.14
Fornitore: Thermo Fisher Scientific

Descrizione: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Codice catalogo: BOSSBS-11800R-A488
UOM: 1 * 100 µl
Codice articolo fornitore: BS-11800R-A488
Codice articolo locale: BOSSBS-11800R-A488
Fornitore: Bioss


Descrizione: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Codice catalogo: BOSSBS-11800R-CY5
UOM: 1 * 100 µl
Codice articolo fornitore: BS-11800R-CY5
Codice articolo locale: BOSSBS-11800R-CY5
Fornitore: Bioss


Descrizione: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Codice catalogo: BOSSBS-11800R-A555
UOM: 1 * 100 µl
Codice articolo fornitore: BS-11800R-A555
Codice articolo locale: BOSSBS-11800R-A555
Fornitore: Bioss


Descrizione: Blu metile
Codice catalogo: ICNA0215264325
UOM: 1 * 25 g
Codice articolo fornitore: 0215264325
Codice articolo locale: ICNA0215264325
Fornitore: MP Biomedicals


Descrizione: L-Serine, EMPROVE® EXPERT USP, Ph. Eur. adatto a essere utilizzato come eccipiente, SAFC®
Codice catalogo: 1.07647.1000
UOM: 1 * 1 kg
Codice articolo fornitore: 1.07647.1000
Codice articolo locale: MERP1.07647.1000
Fornitore: MERCK PRODUCTION CHEMICALS

MSDS


Descrizione: Glicina 99+%, ultrapuro per biologia molecolare
Codice catalogo: J16407.A1
UOM: 1 * 1 kg
Codice articolo fornitore: J16407.A1
Codice articolo locale: ALFAJ16407.A1
Fornitore: Thermo Fisher Scientific


Descrizione: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Codice catalogo: BOSSBS-11800R-A350
UOM: 1 * 100 µl
Codice articolo fornitore: BS-11800R-A350
Codice articolo locale: BOSSBS-11800R-A350
Fornitore: Bioss


Descrizione: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Codice catalogo: BOSSBS-11800R-FITC
UOM: 1 * 100 µl
Codice articolo fornitore: BS-11800R-FITC
Codice articolo locale: BOSSBS-11800R-FITC
Fornitore: Bioss


Descrizione: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterized by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumors (2).
Codice catalogo: BOSSBS-11800R-HRP
UOM: 1 * 100 µl
Codice articolo fornitore: BS-11800R-HRP
Codice articolo locale: BOSSBS-11800R-HRP
Fornitore: Bioss


Descrizione: Vasopressin (AVP), the antidiuretic hormone, is a cyclic nonpeptide that is involved in the regulation of body fluid osmolality (1-3). AVP mediates its effects through a family of G-protein coupled receptors, the vasopressin receptors type V1a, V2 and V3 (also designated V1b) (1,2). The AVP receptor V1a is responsible for several functions, including blood vessel constriction, liver glycogenolysis and platelet adhesion (3). It is detected as a full length protein and a shorter protein, which results from proteolytic cleavage of its amino terminus (4). The V1a receptor is coupled to Gq/11 protein, which increases the intracellular calcium concentration (3). The human AVP receptor V2 gene maps to chromosome Xq28 and is expressed in lung and kidney (5,6). Mutations in the V2 receptor result in nephrogenic diabetes insipidus (NDI), a rare X-linked disorder characterised by the inability of the kidney to concentrate urine in response to AVP (5,7). The AVP Receptor V2 activates the Gs protein and the cyclic AMP second messenger system (7). The AVP receptor V3 is preferentially expressed in the pituitary and stimulates the release of adrenocorticotropic hormone (ACTH) in response to AVP by mobilizing intracellular calcium stores (8). AVP receptor antagonists may have potential therapeutic effects in hypertension, congestive heart failure, nephrotic syndrome and ACTH-secreting tumours (2).
Codice catalogo: BOSSBS-11800R-A680
UOM: 1 * 100 µl
Codice articolo fornitore: BS-11800R-A680
Codice articolo locale: BOSSBS-11800R-A680
Fornitore: Bioss


1 - 16 of 51 021